You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Arrangements being made to vaccinate Haj pilgrims: Union Minister Naqvi

Arrangements are being made to provide coronavirus vaccine to Indian Haj pilgrims, the Union Minister for Minority Affairs Mukhtar Abbas Naqvi said on Tuesday

Haj pilgrimage | Coronavirus Vaccine | Haj pilgrims’ vaccination

ANI  |  General News 

Hajj pilgrims leaves to the Holy City of Makkah
Hajj pilgrims leave for the Holy City of Makkah

Arrangements are being made to provide to Indian Haj pilgrims, the Union Minister for Minority Affairs said on Tuesday.

He was speaking at a meeting of the officials and Haj Group organisers at Haj House here.

"Today discussed various issues concerned to Haj 2021 with officials and Haj Group Organisers at Haj House in Mumbai. Arrangements are being made to give Corona vaccine to all the people who will go to perform Haj from India," the Union Minister informed via Twitter.

The last date for submission of forms for Haj 2021 has been extended till January 10, 2021.

Last month, during a meeting with the Haj Committee here to discuss the preparations and registrations for Haj 2021, Naqvi lauded the committee for making the registration process "100 per cent" digital, in turn making India the "first country" to do so.

In another tweet, the Union Minister on Tuesday slammed the Opposition for raising questions on the measure taken by the Centre to combat the coronavirus pandemic.

"Those people who earlier raised questions on welfare measures taken by Narendra Modi government during the corona crisis, are now trying to create confusion on the Corona vaccines which have been developed by hard-working scientists of our country," he said in a subsequent tweet.

"...Some failed and frustrated political players', who are unable to convince the people, are trying to confuse by using Corona vaccine as confusion rexine."

Last week, Drugs Controller General of India (DCGI) announced "restricted emergency use" for two COVID-19 vaccine candidates -- Bharat Biotech's COVAXIN and Serum Institute of India's Covishield.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, January 06 2021. 07:08 IST